Cytokine Gene Polymorphisms
Working Group Meeting - Slide Shows
Victoria, BC, Canada
May 13, 14, 15, 2002




Monday, May 13
Chair: J. Mytilineos, I. Hutchinson


Cytokine Gene Polymorphisms I. Hutchinson (Ian.Hutchinson@man.ac.uk)
The CGP Component, Study Set Up, Participation, Statistics J. Mytilineos (jmytil@aol.com)
The Phase I and II Panels E. Mickelson (emickels@fhcrc.org)
The IHWC PCR-SSP Kit;   Cytokine-Score J. Mytilineos (jmytil@aol.com)
Cytokine Genotyping by the PCR-SSOP Method. The Belfast Experience D. Middleton (derek.middleton@bll.n-i.nhs.uk)




Chair: A. Castley, M.-T. Lin
Cytokine SNaPshot(ting)D. Turner (david.turner@nbs.nhs.uk)
Genotype in Manchester V. Pravica (Vpravica@fs1.scg.man.ac.uk)
Cytokine typing by the PCR-RFLP Method M.-T. Lin (mtlin@fhcrc.org)
Statistical Analysis of the QC Data (Phase I and II) G. Laux (Gunter_Laux@med.uni-heidelberg.de)
The Phase I + II QC ResultsJ. Mytilineos (jmytil@aol.com)
Alternative Detection MethodsA. Castley (Alison.Castley@health.wa.gov.au)




Tuesday, May 14
Chair: J. Mytilineos, A.C. Goldberg


IL1 Gene Cluster Polymorphisms M. Petrek (martin.petrek@fnol.cz)    A. Slavcev (tosl@medicon.cz)
IL2, TGF beta D. Turner (david.turner@nbs.nhs.uk)
IL4 M. Fasano (mfasano@molinette.piemonte.it)
IL4R G. Saruhan (gsaruhan@istanbul.edu.tr)
IL6, IL10, IL12, TNF alpha V. Pravica (Vpravica@fs1.scg.man.ac.uk)


               

               

Wednesday, May 15
Theatre Symposium IX, Cytokine Gene Polymorphisms
Chair: J. Mytilineos, F. Christiansen


Cytokine Gene Polymorphisms - State of the Art I. Hutchinson (Ian.Hutchinson@man.ac.uk)
CGP Component - Study Concept, Statistics, Participation, Phase I and II Quality Control Results J. Mytilineos (jmytil@aol.com)
Summary of the Phase II Studies I. Hutchinson (Ian.Hutchinson@man.ac.uk)
Future Plans and Prospectives J. Mytilineos (jmytil@aol.com)